famotidine has been researched along with Disease Exacerbation in 4 studies
Famotidine: A competitive histamine H2-receptor antagonist. Its main pharmacodynamic effect is the inhibition of gastric secretion.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Famotidine may increase LAK activity by increasing IL-2 internalization by the IL-2 receptor on lymphocytes." | 5.35 | High-dose intensity pulse interleukin-2 with famotidine has activity in metastatic melanoma. ( King, LA; Liles, DK; Picton, M; Quan, FM; Quan, WD; Tyre, C; Walker, PR, 2008) |
| "The patient was diagnosed with acute tubulointerstitial nephritis caused by cefdinir." | 5.31 | Successful steroid therapy for cefdinir-induced acute tubulointerstitial nephritis with progressive renal failure. ( Fujiwara, T; Hiramori, K; Kawamura, M; Kimura, Y; Maesawa, C; Owada, M, 2001) |
| "The aim of the study was to assess effects of H2-blocker of the IIId generation famotidine (quamatel) on the progression of acute and chronic pancreatitis and intensity of pain in patients with pancreatitis." | 5.09 | [Quamatel in the treatment of acute and chronic pancreatitis]. ( Belousova, EA; Dolgova, MB; Filizhanko, VN; Lovakov, AI; Nikulin, IV; Shemeneva, EG; Zlatkin, AR, 2000) |
| "Famotidine may increase LAK activity by increasing IL-2 internalization by the IL-2 receptor on lymphocytes." | 1.35 | High-dose intensity pulse interleukin-2 with famotidine has activity in metastatic melanoma. ( King, LA; Liles, DK; Picton, M; Quan, FM; Quan, WD; Tyre, C; Walker, PR, 2008) |
| "The patient was diagnosed with acute tubulointerstitial nephritis caused by cefdinir." | 1.31 | Successful steroid therapy for cefdinir-induced acute tubulointerstitial nephritis with progressive renal failure. ( Fujiwara, T; Hiramori, K; Kawamura, M; Kimura, Y; Maesawa, C; Owada, M, 2001) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Quan, WD | 2 |
| Walker, PR | 1 |
| Picton, M | 1 |
| Quan, FM | 2 |
| King, LA | 1 |
| Tyre, C | 1 |
| Liles, DK | 1 |
| Belousova, EA | 1 |
| Zlatkin, AR | 1 |
| Nikulin, IV | 1 |
| Lovakov, AI | 1 |
| Filizhanko, VN | 1 |
| Shemeneva, EG | 1 |
| Dolgova, MB | 1 |
| Kimura, Y | 1 |
| Kawamura, M | 1 |
| Owada, M | 1 |
| Fujiwara, T | 1 |
| Maesawa, C | 1 |
| Hiramori, K | 1 |
2 trials available for famotidine and Disease Exacerbation
| Article | Year |
|---|---|
High-dose intensity pulse interleukin-2 with famotidine in metastatic kidney cancer.
Topics: Aged; Cytokine-Induced Killer Cells; Disease Progression; Drug Administration Schedule; Drug Interac | 2009 |
[Quamatel in the treatment of acute and chronic pancreatitis].
Topics: Acute Disease; Adult; Chronic Disease; Disease Progression; Famotidine; Female; Histamine H2 Antagon | 2000 |
2 other studies available for famotidine and Disease Exacerbation
| Article | Year |
|---|---|
High-dose intensity pulse interleukin-2 with famotidine has activity in metastatic melanoma.
Topics: Aged; Aged, 80 and over; Combined Modality Therapy; Disease Progression; Famotidine; Female; Humans; | 2008 |
Successful steroid therapy for cefdinir-induced acute tubulointerstitial nephritis with progressive renal failure.
Topics: Acute Disease; Acute Kidney Injury; Anti-Infective Agents; Anti-Inflammatory Agents; Biopsy; Bronchi | 2001 |